Maker of OxyContin set to dissolve after judge approves criminal sentence
Purdue Pharma, the maker of OxyContin, is set to be dissolved as a massive legal settlement resolving thousands of lawsuits takes effect.
Purdue Pharma
Breaking down Purdue Pharma opioid settlement
The $7.4 billion settlement with Purdue Pharma was approved by a federal judge. Now local governments will vote on whether to sign onto the deal. The maker of OxyContin is accused of fueling the country's opioid overdose epidemic. Dr. Celine Gounder joins to discuss.
Maura Healey on Canadian trade
Five governors met with Canadian leaders in Boston amid tariff uncertainty. Massachusetts Democratic Gov. Maura Healey joins "The Takeout" with more.
Who gets the $7.4 billion Purdue settlement money?
A federal bankruptcy judge will soon decide whether to approve a nearly $7.4 billion settlement involving Purdue Pharma, which made the pain medication OxyContin. Scott MacFarlane looks at the potential impact of what would be a landmark deal.
More states back $7.4 billion Purdue Pharma opioid settlement
More states, territories and Washington, D.C., have signed on to a settlement with drugmaker Purdue Pharma and the Sackler family over the opioid crisis, officials said.
Walgreens to pay $300 million settlement in opioid prescriptions case
Walgreens has agreed to pay the government $300 million to settle claims that it unlawfully filled millions of invalid prescriptions.
Inside the Purdue Pharma bankruptcy case
Here's why people alleging Purdue Pharma's opioids harmed them may not see much of the proposed $7.4 billion settlement in a bankruptcy case
For opioid victims, payouts fall short while governments reap millions
Pharmaceutical companies accused of fueling the nation's opioid crisis are paying state and local governments billions of dollars in legal settlements. But how much are victims getting?
Statement of Purdue Pharma to 60 Minutes
Purdue Pharma provided the following statement for 60 Minutes' report Sunday, "The Settlement."
Claimant: Opioid victims not getting justice in proposed Purdue settlement
Here's why people alleging Purdue Pharma's opioids harmed them may not see much of the proposed $7.4 billion settlement in a bankruptcy case.
Potential $7.4B Purdue Pharma opioid settlement frustrates some victims
Opioid victims are not getting a "fair shake" in potential $7.4 billion settlement, a claimant in the Purdue Pharmacy bankruptcy case says.
Sacklers, Purdue Pharma reach $7.4B settlement with 15 states over opioid crisis
The Sackler family will pay the vast majority of the settlement — a total of $6.5 billion over 15 years.
Supreme Court rulings for FDA, Purdue Pharma
In two rulings released Thursday, the Supreme Court has blocked both the EPA good neighbor rule meant to fight air pollution and Purdue Pharma's bankruptcy plan that would've broadly protected the Sackler family from civil lawsuits related to their role in the opioid epidemic. Former federal prosecutor Scott Fredericksen joined CBS News to discuss the decisions.
The Supreme Court is nearing the end of its term. Here are the cases it still has to decide.
The Supreme Court is set to issue decisions in the coming weeks in more than a dozen cases involving issues like abortion, guns and sweeping immunity for former President Donald Trump.
Big Pharma CEOs testify in Senate hearing
Appearing before a Senate committee Thursday, the CEOs of Johnson and Johnson, Merck and Bristol Myers Squibb answered questions as to why the price of their drugs are three times higher in the U.S. than in 33 other wealthy countries. Scott MacFarlane has more.
Supreme Court weighs legal shield for Sacklers
The Supreme Court heard arguments Monday in a case over a settlement for victims of the opioid crisis. Approving the settlement would mean shielding the Sackler family, the former owners of Purdue Pharma, from future lawsuits. Jan Crawford reports.
Purdue Pharma bankruptcy shielding Sackler family heads to Supreme Court
Purdue Pharma, the maker of OxyContin, filed for Chapter 11 bankruptcy protection in September 2019 after it faced scores of lawsuits related to the opioid crisis.
Supreme Court weighs Purdue Pharma bankruptcy
The U.S. Supreme Court will hear oral arguments Monday about the legality of a $6 billion bankruptcy agreement for Purdue Pharma, the manufacturer of OxyContin. While many families of victims support the deal, which would fulfill financial settlements, it would shield the powerful Sackler family from thousands of potential lawsuits. CBS News' Jan Crawford reports.
Opioid settlement challenge in Supreme Court
A multibillion-dollar bankruptcy settlement with the maker of Oxycontin will be challenged Monday at the Supreme Court. Justices are weighing whether the wealthy Sackler family, which owned Purdue Pharma, can evade lawsuits over the company's powerful painkillers linked to hundreds of thousands of deaths. CBS News chief legal correspondent Jan Crawford reports.
Biggest cases in Supreme Court's new term
The Supreme Court returned for its new term on Monday with several potentially major cases ahead. Jimmy Hoover, Supreme Court reporter at the National Law Journal, joins CBS News to take a look at some of the most important and controversial cases on the docket.
Purdue Pharma settlement put on hold
The Supreme Court put a settlement by Purdue Pharma on hold Friday. The settlement would have shielded the Sackler family, the clan behind the company and its alleged role in the opioid crisis, from future civil litigation. Jeff Glor has more.
Supreme Court blocks Purdue Pharma settlement
The Supreme Court has temporarily blocked a Purdue Pharma settlement that would shield the Sackler family from civil lawsuits related to the opioid crisis. Author Barry Meier, who wrote the book "Pain Killer" about the Sacklers and Purdue Pharma, weighs in on the settlement.
2/11: CBS Evening News
3 dead in Grand Canyon helicopter crash; Food for the heart and soul: The ramen noodle chef redefining cafeteria cuisine
Purdue Pharma to stop promoting opioids
One of the largest suppliers of OxyContin said this weekend it will no longer promote the powerful painkiller to doctors. CBS News' Nikki Battiste reports on the opioid market shakeup.
Purdue CEO cast blame on opioid victims in old emails
"Abusers aren't victims; they are the victimizers," member of family that owns the maker of OxyContin wrote in 2001
Hegseth to announce 20% cut to generals and admirals
Trump and major AI executives sign "morally binding" voluntary controls
Exclusive
Transcript shows campus police interview with Jane Doe in Cornell rape case
Live
Iran's military says war will only end when U.S. admits defeat
Flight to Tel Aviv diverts to Saudi Arabia after reported feud between pilots
U.S. military declares end of anti-ISIS Operation Inherent Resolve in Iraq
Exclusive
Sen. Josh Hawley introduces bill aimed at stopping abuse of Flock cameras
Jack Smith defends handling of Trump probes at heated Senate hearing
